RAF1 and small cell lung carcinoma: Subsequently, NNK activated the Raf-1/MAP kinase pathway by stimulating the release of the autocrine growth factor 5-hydroxytryptamine, leading to phosphorylation of c-myc, thereby regulating the growth of an important subset of small cell lung cancer (SCLC) and pulmonary neuroendocrine cells (PNECs) [59].